Protein Design
Protein design generates sequences and/or structures intended to fold, bind, or function as specified, including de novo backbones and sequence design for a target structure.
One conditional view is:
where is a sequence, is a backbone or structural context, and is a design condition such as binding, fold, or function.
Protein design can also generate coordinates:
or joint sequence-structure objects:
The claim changes depending on whether the model generates sequence, backbone, side chains, complex pose, or only ranks candidates.
Design Targets
| Target | Generated Object | Evidence Boundary |
|---|---|---|
| Sequence design | sequence for a fixed backbone or fold | sequence recovery and predicted structure are not enough for function |
| Backbone design | coordinates or fold scaffold | geometry plausibility does not prove foldability or expression |
| Binder design | sequence, backbone, or complex against a target | docking or predicted complex score is not experimental binding |
| Functional design | sequence or structure with desired activity | proxy model score is not functional validation |
| Motif scaffolding | scaffold around constrained residues or motif | motif placement must be separated from global stability |
Objective Patterns
Autoregressive sequence design can be written as:
Diffusion or flow-style structure design often models a path over coordinates:
where is a noisy or intermediate structure, is a denoising or velocity field, and is the design condition.
Many workflows add filtering or guidance:
where can be a folding model, structure predictor, docking score, energy model, classifier, or human-defined rule. The reported claim must state whether quality comes from the generator, the filter, or both.
Claim Ladder
| Claim | Evidence needed |
|---|---|
| sequence is plausible | composition, language-model score, diversity, training similarity |
| structure is plausible | backbone geometry, clashes, local quality, fold confidence |
| sequence folds to intended structure | independent structure prediction or experimental structure |
| binder is plausible | interface geometry, negative controls, target specificity checks |
| function is plausible | assay-relevant model or experiment, not only fold confidence |
| experimentally validated | wet-lab evidence with conditions and failure denominator |
Evaluation Contract
| Check | Why |
|---|---|
| Training similarity | near-template or homologous designs can look novel only superficially |
| Structural validity | backbone geometry, clashes, side-chain packing, and fold confidence test different failures |
| Conditional satisfaction | designs must satisfy the requested fold, motif, target, or function |
| Diversity | many high-scoring designs may be near-duplicates |
| Experimental status | in-silico validation must not be written as wet-lab success |
| Negative controls | generated designs should be compared with simple baselines or shuffled conditions |
| Candidate accounting | attempted, filtered, failed, and retained designs must be counted separately |
| Split boundary | training similarity, homologs, templates, and target-family leakage must be checked |
Why It Matters
- Enables novel binders, enzymes, and scaffolds beyond natural proteins.
- Combines structure generation with sequence design and validation.
- Computational success must hold up against experimental reality.
Checks
- Are designs evaluated for foldability and structural consistency?
- Does the model exploit training data instead of generalizing?
- How are designs validated beyond in-silico metrics?
- Is the claim about sequence recovery, structure plausibility, binding, function, or experimental validation?
- Are generated samples filtered by a separate model that owns part of the final claim?
- Are failed or filtered designs included in the denominator?
- Is the validation model independent from the generator’s training signal?
- Does the design claim depend on sequence, structure, complex, or experimental evidence?